Description

Cilostazol Related Compound C (50 Mg) (1-(4-(5-Cyclohexyl-1H-Tetrazol-1-Yl)Butyl)-6-(4-(1-Cyclohexyl-1H-Tetrazol-5-Yl)Butoxy)-3,4-Dihydroquinolin-2(1H)-One) is a high-purity reference standard critical for analytical and research applications. This compound is essential for ensuring the quality, safety, and efficacy of pharmaceutical products by serving as a key impurity marker. It is primarily needed by pharmaceutical manufacturers, analytical laboratories, and R&D facilities involved in the development, quality control, and regulatory compliance of the antiplatelet drug Cilostazol.

Application

• Pharmaceutical Reference Standard: Used as a certified reference material (CRM) for the identification and quantification of related substances in Cilostazol Active Pharmaceutical Ingredient (API) and finished dosage forms.
• Analytical Method Development & Validation: Serves as a critical component in developing and validating HPLC, UPLC, and other chromatographic methods for impurity profiling.
• Quality Control & Assurance (QC/QA): Employed in routine batch testing to monitor and control impurity levels, ensuring compliance with pharmacopeial standards (e.g., USP, EP).
• Stability Studies: Used to track the formation of degradation products in Cilostazol formulations under various stress conditions.
• Regulatory Submissions: Provides essential data for drug master files (DMFs), investigational new drug (IND) applications, and new drug applications (NDAs).
• Research & Development: Facilitates studies on the metabolism, pharmacokinetics, and toxicological profile of Cilostazol and its related compounds.

Basic Information

Item	Details
Product Name	Cilostazol Related Compound C (50 Mg) (1-(4-(5-Cyclohexyl-1H-Tetrazol-1-Yl)Butyl)-6-(4-(1-Cyclohexyl-1H-Tetrazol-5-Yl)Butoxy)-3,4-Dihydroquinolin-2(1H)-One)
CAS No.	865792-18-3
Molecular Formula	C36H53N9O2
Molecular Weight	643.87 g/mol
Synonyms	Cilostazol Impurity C; Cilostazol Related Substance C; 1-(4-(5-Cyclohexyl-1H-Tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one; Cilostazol Compound C; OPC-13013 Related Compound C; 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-1-[4-(5-cyclohexyl-1H-tetrazol-1-yl)butyl]-3,4-dihydro-2(1H)-quinolinone
EINECS	Contact for details

Quality Control

Our Cilostazol Related Compound C is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation (IR, MS), to ensure it meets the high standards required for pharmaceutical reference materials. A comprehensive Certificate of Analysis (COA) detailing purity, assay, and impurity profile is provided with every shipment to support your regulatory and quality assurance needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and must be kept in a desiccated environment to maintain stability and purity.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Purity (HPLC)	≥ 98.0%
Assay	95.0% - 105.0% (on anhydrous basis)
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.